Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 1 3Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 68Breast Neoplasms 58Carcinoma, Non-Small-Cell Lung 36Triple Negative Breast Neoplasms 28Squamous Cell Carcinoma of Head and Neck 15Neoplasms 11Head and Neck Neoplasms 11Lung Neoplasms 10Esophageal Squamous Cell Carcinoma 10Neoplasm Metastasis 7Stomach Neoplasms 6Melanoma 6Adenocarcinoma 6Esophageal Neoplasms 5Cholangiocarcinoma 5Advanced Pancreatic Cancer 5Inflammatory Breast Neoplasms 4Gallbladder Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma 4Small Cell Lung Carcinoma 3Recurrence 3Pathologic Complete Response 3Ovarian Neoplasms 3Neoplasms by Site 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma, Squamous Cell 3Uveal Melanoma 2Uterine Cervical Neoplasms 2

Interventions

pembrolizumab 45Paclitaxel 8Cisplatin 8Carboplatin 8lenvatinib 7Pemetrexed 5Gemcitabine 4camrelizumab 3Docetaxel 3Capecitabine 3epacadostat 2avelumab 2Fluorouracil 2Cetuximab 2Acetaminophen 2vicriviroc 1sinoporphyrin sodium 1penpulimab 1olaparib 1etoposide phosphate 1enzalutamide 1balstilimab 1apatinib 1Temozolomide 1Tadalafil 1Standard of Care 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy 1Radiosurgery 1Poly(ADP-ribose) Polymerase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Parkinson Disease 4, Autosomal Dominant Lewy Body × 130-nm albumin-bound paclitaxel × Clear all
NCT04530227 2020-11-13

Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

Data powered by HemOnc (CC BY 4.0) Colophon âš¡